Image de couverture de livre

NLRP7 engagement in transformation and etiology of chronic disease.

Fuente: Zenodo

Enregistré dans:

Détails bibliographiques
Auteur principal:	Mamoor, Shahan
Format:	Recurso digital
Publié:	Zenodo 2025
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Adirf activation in chronic disease.
par: Mamoor, Shahan
Publié: (2025)

NLRP11 detects activation of CIDE cell death effectors.
par: Mamoor, Shahan
Publié: (2025)

Ep300 activation defines a common epigenetic route in chronic disease.
par: Mamoor, Shahan
Publié: (2025)

FCGRT functions in senescence and transformation.
par: Mamoor, Shahan
Publié: (2025)

ECT2 is a sensitive and specific marker of transformation in the human breast.
par: Mamoor, Shahan
Publié: (2025)

ECT2 is a sensitive and specific marker of transformation in the human breast.
par: Mamoor, Shahan
Publié: (2025)

SLX1B is active during transformation and controls relapse and resistance in human cancer.
par: Mamoor, Shahan
Publié: (2025)

Gpr84 is a marker of the inflammatory bowel disease Crohn's Disease.
par: Mamoor, Shahan
Publié: (2026)

Genes that function in axon guidance are associated with disease progression in breast and lung cancer.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: MSL1.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ADGRF1.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CD80.
par: Mamoor, Shahan
Publié: (2025)

Phosphatase targeting in HER2+ breast cancer to prevent and treat CNS disease: PTPN13.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CNTNAP2.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CPAMD8.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDC45.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ENPP3.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CMC2.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DNAAF5.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EFNA4.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CHORDC1.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DEPDC1.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ERO1A.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: FAM129B.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: SLC1A1.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: CDK7.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EIF4G1.
par: Mamoor, Shahan
Publié: (2026)

H7N9 PA-X silences Ifi6.
par: Mamoor, Shahan
Publié: (2026)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: HOXB7.
par: Mamoor, Shahan
Publié: (2025)

The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
par: Mamoor, Shahan
Publié: (2025)

The homeobox transcription factor TCF7 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: TGFBI.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MTF1.
par: Mamoor, Shahan
Publié: (2025)

Xist is activated during resistance in triple negative breast cancer in vitro.
par: Mamoor, Shahan
Publié: (2025)

Importin 8 is activated in childhood brain cancer.
par: Mamoor, Shahan
Publié: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: MAT1A.
par: Mamoor, Shahan
Publié: (2025)

Telomerase control of Xist through Trf2.
par: Mamoor, Shahan
Publié: (2025)